Myasthenia gravis (MG) is a chronic, autoimmune, progressive neuromuscular disease that affects the neuromuscular junction. The disease occurs because the organism creates antibodies against acetylcholine receptors in the neuromuscular synapse, which prevents the transmission of impulses from the nerve fiber to the muscle. The main feature of Myasthenia Gravis is skeletal muscle weakness. In the morning and after a long rest, the weakness is not so pronounced, while during the day and evening, increased weakness is observed. Symptoms of MG can be divided into ocular symptoms, bulbar symptoms and a generalized form. In most patients, ocular symptoms (ptosis and diplopia) first appear, which can then progress to a generalized form. Myasthenic crisis is a life-threatening condition where the respiratory musculature is affected. During the physiotherapy assessment, the SOAP method is applied, as well as functional tests and measurements to gain insight into the patient's functional status, i.e. to determine functional limitations. Based on the therapy plan, the procedures to be carried out in the physiotherapy intervention are determined. The goals of physical therapy in patients with MG are to prevent a decrease in a person's functional ability to maintain as much independence as possible during work and daily activities and to maintain independent movement for as long as possible. The physiotherapist plans and implements an individual program of exercises and physical procedures according to each patient and his condition and capabilities so that at the end the therapy program has a positive effect on the disease.